Baidu
map

创建带有网膜脂肪增强游离皮瓣的生物乳房植入物

2022-04-19 宁咸襄 MedSci原创

患有肌皮或筋膜皮肤软组织炎的女性在乳腺切除术后选择供区进行乳房重建,大多局限于植入物。对于那些不想要或存在基于植入物的重建禁忌症的患者便需要相应的替代物。

患有肌皮或筋膜皮肤软组织炎的女性在乳腺切除术后选择供区进行乳房重建,大多局限于植入物。对于那些不想要或存在基于植入物的重建禁忌症的患者便需要相应的替代物。

从大网膜制作三维乳房丘的一个主要挑战是其平坦、不成形的形状。该研究描述了一种新颖独特的方法,在保留乳头的乳房切除术后,使用包含在无粘膜真皮基质模具内的大网膜脂肪游离皮瓣。

图1 文章来源

该文章报告了一种新的技术,使用大网膜脂肪增强的游离皮瓣来创建一个与乳房植入物具有相似形状和投影的自体乳房。

2019年至2020年期间,研究者确定了三名需要单侧重建的乳腺癌患者。受试者都没有足够的传统自体部位,并且都反对使用植入物。为此,研究者行保留乳头的乳房切除术,并在腹腔镜下取大网膜,进行体外脂肪移植,然后将其包裹在脱细胞真皮基质中进行微血管吻合。

图2所有患者乳房、大网膜、脂肪移植物和大网膜脂肪增强无细胞真皮基质游离皮瓣的天然和重建重量的比较

结果表明,三名患者的体重指数分别为17.6、25和28.3 kg/m2。每个个体的乳房切除术标本和相应的大网膜加脂肪移植重量分别为113.7/228、271/293和270/360克。

未发生术后并发症。重建的乳房仍然柔软。在术后6个月时,受试者乳房体积稳定,没有脂肪坏死的迹象。

这是第一例使用大网膜脂肪游离皮瓣成功进行结构性乳房重建的报道。这项技术使乳房看起来自然,投影与植入物相当,美学效果优于之前使用网膜瓣的尝试。对于那些希望自体乳房重建但不想或不符合更传统自体乳房重建方法的患者,它提供了一种可靠的自体替代物。

 

文章来源:

Nguyen, Dung H. M.D., Pharm.D.; Ma, Irene T. M.D.; Choi, Youna K. M.D.; Zak, Yulia M.D.; Dua, Monica M. M.D.; Wapnir, Irene L. M.D. Creating a Biological Breast Implant with an Omental Fat-Augmented Free Flap, Plastic and Reconstructive Surgery: April 2022 - Volume 149 - Issue 4 - p 832-835

doi: 10.1097/PRS.0000000000008963

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1797711, encodeId=f24a1e9771164, content=<a href='/topic/show?id=8d1423633a6' target=_blank style='color:#2F92EE;'>#乳房植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23633, encryptionId=8d1423633a6, topicName=乳房植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Tue Jul 26 16:22:56 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215955, encodeId=ca75121595542, content=<a href='/topic/show?id=291a23643c2' target=_blank style='color:#2F92EE;'>#乳房重建#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23643, encryptionId=291a23643c2, topicName=乳房重建)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Sun May 01 09:48:56 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214417, encodeId=a633121441e10, content=认真***, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b6e2403217, createdName=1235bd28m70暂无昵称, createdTime=Tue Apr 26 10:09:11 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212628, encodeId=5453121262867, content=有趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b438105599, createdName=ms5000000462690030, createdTime=Tue Apr 19 19:38:39 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425661, encodeId=b20e142566128, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490949, encodeId=8454149094959, content=<a href='/topic/show?id=fb916268636' target=_blank style='color:#2F92EE;'>#植入物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62686, encryptionId=fb916268636, topicName=植入物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628846382, createdName=linagood, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520804, encodeId=1a5a1520804e8, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1797711, encodeId=f24a1e9771164, content=<a href='/topic/show?id=8d1423633a6' target=_blank style='color:#2F92EE;'>#乳房植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23633, encryptionId=8d1423633a6, topicName=乳房植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Tue Jul 26 16:22:56 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215955, encodeId=ca75121595542, content=<a href='/topic/show?id=291a23643c2' target=_blank style='color:#2F92EE;'>#乳房重建#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23643, encryptionId=291a23643c2, topicName=乳房重建)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Sun May 01 09:48:56 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214417, encodeId=a633121441e10, content=认真***, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b6e2403217, createdName=1235bd28m70暂无昵称, createdTime=Tue Apr 26 10:09:11 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212628, encodeId=5453121262867, content=有趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b438105599, createdName=ms5000000462690030, createdTime=Tue Apr 19 19:38:39 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425661, encodeId=b20e142566128, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490949, encodeId=8454149094959, content=<a href='/topic/show?id=fb916268636' target=_blank style='color:#2F92EE;'>#植入物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62686, encryptionId=fb916268636, topicName=植入物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628846382, createdName=linagood, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520804, encodeId=1a5a1520804e8, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1797711, encodeId=f24a1e9771164, content=<a href='/topic/show?id=8d1423633a6' target=_blank style='color:#2F92EE;'>#乳房植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23633, encryptionId=8d1423633a6, topicName=乳房植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Tue Jul 26 16:22:56 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215955, encodeId=ca75121595542, content=<a href='/topic/show?id=291a23643c2' target=_blank style='color:#2F92EE;'>#乳房重建#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23643, encryptionId=291a23643c2, topicName=乳房重建)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Sun May 01 09:48:56 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214417, encodeId=a633121441e10, content=认真***, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b6e2403217, createdName=1235bd28m70暂无昵称, createdTime=Tue Apr 26 10:09:11 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212628, encodeId=5453121262867, content=有趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b438105599, createdName=ms5000000462690030, createdTime=Tue Apr 19 19:38:39 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425661, encodeId=b20e142566128, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490949, encodeId=8454149094959, content=<a href='/topic/show?id=fb916268636' target=_blank style='color:#2F92EE;'>#植入物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62686, encryptionId=fb916268636, topicName=植入物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628846382, createdName=linagood, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520804, encodeId=1a5a1520804e8, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=)]
    2022-04-26 1235bd28m70暂无昵称

    认真***

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1797711, encodeId=f24a1e9771164, content=<a href='/topic/show?id=8d1423633a6' target=_blank style='color:#2F92EE;'>#乳房植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23633, encryptionId=8d1423633a6, topicName=乳房植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Tue Jul 26 16:22:56 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215955, encodeId=ca75121595542, content=<a href='/topic/show?id=291a23643c2' target=_blank style='color:#2F92EE;'>#乳房重建#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23643, encryptionId=291a23643c2, topicName=乳房重建)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Sun May 01 09:48:56 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214417, encodeId=a633121441e10, content=认真***, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b6e2403217, createdName=1235bd28m70暂无昵称, createdTime=Tue Apr 26 10:09:11 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212628, encodeId=5453121262867, content=有趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b438105599, createdName=ms5000000462690030, createdTime=Tue Apr 19 19:38:39 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425661, encodeId=b20e142566128, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490949, encodeId=8454149094959, content=<a href='/topic/show?id=fb916268636' target=_blank style='color:#2F92EE;'>#植入物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62686, encryptionId=fb916268636, topicName=植入物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628846382, createdName=linagood, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520804, encodeId=1a5a1520804e8, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=)]
    2022-04-19 ms5000000462690030

    有趣

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1797711, encodeId=f24a1e9771164, content=<a href='/topic/show?id=8d1423633a6' target=_blank style='color:#2F92EE;'>#乳房植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23633, encryptionId=8d1423633a6, topicName=乳房植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Tue Jul 26 16:22:56 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215955, encodeId=ca75121595542, content=<a href='/topic/show?id=291a23643c2' target=_blank style='color:#2F92EE;'>#乳房重建#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23643, encryptionId=291a23643c2, topicName=乳房重建)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Sun May 01 09:48:56 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214417, encodeId=a633121441e10, content=认真***, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b6e2403217, createdName=1235bd28m70暂无昵称, createdTime=Tue Apr 26 10:09:11 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212628, encodeId=5453121262867, content=有趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b438105599, createdName=ms5000000462690030, createdTime=Tue Apr 19 19:38:39 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425661, encodeId=b20e142566128, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490949, encodeId=8454149094959, content=<a href='/topic/show?id=fb916268636' target=_blank style='color:#2F92EE;'>#植入物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62686, encryptionId=fb916268636, topicName=植入物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628846382, createdName=linagood, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520804, encodeId=1a5a1520804e8, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=)]
    2022-04-19 sunylz
  6. [GetPortalCommentsPageByObjectIdResponse(id=1797711, encodeId=f24a1e9771164, content=<a href='/topic/show?id=8d1423633a6' target=_blank style='color:#2F92EE;'>#乳房植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23633, encryptionId=8d1423633a6, topicName=乳房植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Tue Jul 26 16:22:56 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215955, encodeId=ca75121595542, content=<a href='/topic/show?id=291a23643c2' target=_blank style='color:#2F92EE;'>#乳房重建#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23643, encryptionId=291a23643c2, topicName=乳房重建)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Sun May 01 09:48:56 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214417, encodeId=a633121441e10, content=认真***, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b6e2403217, createdName=1235bd28m70暂无昵称, createdTime=Tue Apr 26 10:09:11 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212628, encodeId=5453121262867, content=有趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b438105599, createdName=ms5000000462690030, createdTime=Tue Apr 19 19:38:39 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425661, encodeId=b20e142566128, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490949, encodeId=8454149094959, content=<a href='/topic/show?id=fb916268636' target=_blank style='color:#2F92EE;'>#植入物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62686, encryptionId=fb916268636, topicName=植入物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628846382, createdName=linagood, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520804, encodeId=1a5a1520804e8, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=)]
    2022-04-19 linagood
  7. [GetPortalCommentsPageByObjectIdResponse(id=1797711, encodeId=f24a1e9771164, content=<a href='/topic/show?id=8d1423633a6' target=_blank style='color:#2F92EE;'>#乳房植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23633, encryptionId=8d1423633a6, topicName=乳房植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Tue Jul 26 16:22:56 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215955, encodeId=ca75121595542, content=<a href='/topic/show?id=291a23643c2' target=_blank style='color:#2F92EE;'>#乳房重建#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23643, encryptionId=291a23643c2, topicName=乳房重建)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Sun May 01 09:48:56 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214417, encodeId=a633121441e10, content=认真***, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b6e2403217, createdName=1235bd28m70暂无昵称, createdTime=Tue Apr 26 10:09:11 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212628, encodeId=5453121262867, content=有趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b438105599, createdName=ms5000000462690030, createdTime=Tue Apr 19 19:38:39 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425661, encodeId=b20e142566128, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490949, encodeId=8454149094959, content=<a href='/topic/show?id=fb916268636' target=_blank style='color:#2F92EE;'>#植入物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62686, encryptionId=fb916268636, topicName=植入物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628846382, createdName=linagood, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520804, encodeId=1a5a1520804e8, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Tue Apr 19 10:22:56 CST 2022, time=2022-04-19, status=1, ipAttribution=)]
    2022-04-19 jiyangfei

相关资讯

化疗和放疗对乳房重建中脱细胞真皮基质的炎症反应、新生血管形成和包膜形成的影响

该研究作为BREASTrial的一部分,评估了在乳房再造过程中使用脱细胞真皮基质、异体真皮和真皮基质时,化疗和放射治疗对炎症、新生血管和包膜形成的组织学影响。

这项技术实现无疤痕乳房再造,并且可以恢复乳房区域的感觉!

使用 PALLL 进行乳房再造是一种微创替代方法,可用于重建和重塑有感觉的乳房,其中由乳房周围的环募集的血管化皮瓣与脂肪移植相结合。与传统的乳房重建方法相比,感觉的恢复是一项重大突破。

脂肪移植可以改善乳房重建的结果,同时减轻放疗的负面影响

预防性乳房切除术前脂肪移植是一种减少早期并发症和避免术后并发症高风险患者植入物丢失的新策略。

摘取腹壁深下动脉和静脉的复合动脉和静脉移植:一种安全的五步制备方法

随着皮瓣的使用和自体乳房重建选项的增加,自体乳房重建的复杂性也在增加。尽管显微外科的许多重要进展使显微外科手术能够提高皮瓣的存活率,但在技术上仍存在一些棘手的问题,比如血管不匹配和带蒂根长度短。

即刻两阶段乳房重建术中照射后扩张器与植入物交换的更佳时机

乳腺癌术后放射治疗的适应证在基于植入物的乳房重建中适当放宽。据报道,乳腺癌术后放射治疗应该在组织扩张器放置后还是永久性植入物放置后完成仍存在争议性。

良好的术前心理竟然可以减少乳房重建术后并发症

心理因素被广泛理解为有助于整体健康,但它们对伤口愈合的作用还没有很好地定义。术前身体形象等心理因素与术后并发症的相关性资料有限。

拓展阅读

JAMA Surg:自体脂肪移植vs植入物,哪种乳房重建更受乳腺癌患者青睐?

JAMA Surg:使用扩张装置进行自体脂肪转移或植入物的全乳房重建对乳腺癌患者生活质量的影响:一项随机临床试验

PRS:自体脂肪移植不同处理方法临床效果的前瞻性随机比较。

随着脂肪移植应用逐渐广泛,移植物处理也愈发受到临床重视。在移植过程中有三个关键步骤——收获、加工和移植,其中每个步骤都有几个可能影响移植效率和效果的变量。

PRS:脱细胞真皮基质有利地调节手术后的愈合反应

事实上,使用无细胞真皮基质可能会降低囊性挛缩率,并有利于分阶段进行胸前乳房重建的扩展。

PRS:乳房切除术前固定术在乳房重建中的作用

随着时间的推移,保留乳头的乳房切除术的适应症已扩大范围。但对于乳房肿大或下垂的患者,行保留乳头乳房切除术仍有发生皮瓣或乳头乳晕复合坏死的风险。因此需要一些干预来减小风险,保证手术效果。

乳房重建90 天时的临床和健康相关生活质量结果

在胸前放置组织扩张器进行两期植入性乳房重建可潜在地减少胸壁发病率和术后疼痛。

乳房再造手术决策中的认知偏差和治疗选择

了解医学专家及其患者如何处理和传递信息对于高效的医疗保健专业愿景至关重要。

乳腺癌患者乳房重建决策指导的最佳证据总结

浙江中医药大学护理学院 · 2024-04-05

乳腺肿瘤整形与乳房重建专家共识(2022年版)

中国抗癌协会乳腺癌专业委员会(CACA-CBCS,Chinese Anti-Cancer Association, Committee of Breast Cancer Society) · 2022-09-30

乳腺癌术后乳房重建中国专家共识(2019版)

中华医学会外科学分会 乳腺外科学组 · 2019-11-30

2014 ASPS临床实践指南:应用扩展器和植入物进行乳房重建

美国整形外科医师学会(ASPS,American Society of Plastic Surgeons) · 2014-10-20

Baidu
map
Baidu
map
Baidu
map